Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Arming the immune system

Immune stimulation

Vaccines can be administered orally, nasally or by injection: into the muscle mass, into the layer between skin and muscle or into the outer layer of skin. They stimulate an immune response that gives the body the ability to mount a swifter defence to the same pathogen if it is encountered again.

Source: WHO/CDC/; Graphic: Alisdair Macdonald

Vaccine varieties

There are several types of vaccine in use, each with their own strengths and weaknesses. Many are administered along with adjuvants — substances such as aluminium salts, lipids and RNA that strengthen the immune response.

Source: US Dept Health & Human Services/; Graphic: Alisdair Macdonald

Building coverage

Vaccines initially developed in the 1950s and 1960s, such as those for polio and measles, are commonly administered globally. Those introduced more recently, such as that for rotavirus, are less widely used.

Source: WHO; Graphic: Alisdair Macdonald

The luxury of hesitancy

Although 79% of people globally think that vaccines are safe, trust varies widely between nations. Europe has some of the lowest levels of perceived safety — a finding that might partly explain the surge in measles cases seen in Ukraine in 2018. But other factors besides hesitancy to vaccinate also affect the spread of infections.

Source: Gallup Wellcome Global Monitor 2018 (Wellcome, 2019); Graphic: Alisdair Macdonald

Saving lives

Case numbers of certain infectious diseases in the United States dropped precipitously after effective vaccines for each were widely adopted.

Source: S. W. Roush et al. J. Am. Med. Assoc. 298, 2155–2163 (2007)/CDC; Graphic: Alisdair Macdonald

Long road to new vaccines

Development programmes are under way for a number of deadly diseases that currently lack a vaccine. In many cases, the pathogen responsible was identified decades ago, but effective vaccination strategies have proved elusive.

Source: S. Vanderslott & M. Roser (2019)/WHO; Graphic: Alisdair Macdonald

Nature 575, S44-S45 (2019)


This article is part of Nature Outlook: Vaccines, an editorially independent supplement produced with the financial support of third parties. About this content.


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links